These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 12504930)

  • 1. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
    Colvin J; Bower C; Dickinson JE; Sokol J
    Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
    Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal ultrasonic diagnosis and Down's syndrome].
    Salvesen KA; Eik-Nes SH; Tuveng JM; Sviggum O; Møller P; van der Hagen CB
    Tidsskr Nor Laegeforen; 1990 Feb; 110(6):701-4. PubMed ID: 2138828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief reports decline of Down's syndrome after abortion reform in New York State.
    Hansen H
    Am J Ment Defic; 1978 Sep; 83(2):185-8. PubMed ID: 151507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on population-based prenatal screening and diagnosis of Down's syndrome in Jiangsu province].
    Liu QL; Hu YL; Xu ZF; Wang LJ; Sun Q; Lin N; Xu XY; Liu Y; Zhang JW; Tong JS; Wang XH; He J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):340-2. PubMed ID: 20533279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Down's syndrome in a pregnant population in Finland.
    Marttala J; Yliniemi O; Gissler M; Nieminen P; Ryynanen M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):715-7. PubMed ID: 20218932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic identification of second-trimester fetuses with Down's syndrome.
    Benacerraf BR; Gelman R; Frigoletto FD
    N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
    Calda P; Sípek A; Gregor V
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study.
    Hall S; Bobrow M; Marteau TM
    BMJ; 2000 Feb; 320(7232):407-12. PubMed ID: 10669444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.